These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 1348191)

  • 1. Polymer encapsulated neurotransmitter secreting cells. Potential treatment for Parkinson's disease.
    Tresco PA; Winn SR; Aebischer P
    ASAIO J; 1992; 38(1):17-23. PubMed ID: 1348191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term enhanced chromaffin cell survival and behavioral recovery in hemiparkinsonian rats with co-grafted polymer-encapsulated human NGF-secreting cells.
    Date I; Shingo T; Ohmoto T; Emerich DF
    Exp Neurol; 1997 Sep; 147(1):10-7. PubMed ID: 9294398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional recovery in hemiparkinsonian primates transplanted with polymer-encapsulated PC12 cells.
    Aebischer P; Goddard M; Signore AP; Timpson RL
    Exp Neurol; 1994 Apr; 126(2):151-8. PubMed ID: 7925816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adrenal chromaffin cells as transplants in animal models of Parkinson's disease.
    Hansen JT; Bing GY; Notter MF; Kordower JH; Fiandaca MS; Gash DM
    J Electron Microsc Tech; 1989 Aug; 12(4):308-15. PubMed ID: 2671302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transplantation of polymer encapsulated neurotransmitter secreting cells: effect of the encapsulation technique.
    Aebischer P; Winn SR; Tresco PA; Jaeger CB; Greene LA
    J Biomech Eng; 1991 May; 113(2):178-83. PubMed ID: 1875690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neural transplantation and trophic factors in Parkinson's disease: special reference to chromaffin cell grafting, NGF support from pretransected peripheral nerve, and encapsulated dopamine-secreting cell grafting.
    Date I; Ohmoto T
    Exp Neurol; 1996 Feb; 137(2):333-44. PubMed ID: 8635549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cografting with polymer-encapsulated human nerve growth factor-secreting cells and chromaffin cell survival and behavioral recovery in hemiparkinsonian rats.
    Date I; Ohmoto T; Imaoka T; Ono T; Hammang JP; Francis J; Greco C; Emerich DF
    J Neurosurg; 1996 Jun; 84(6):1006-12. PubMed ID: 8847564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective and restorative effects of intrastriatal grafting of encapsulated GDNF-producing cells in a rat model of Parkinson's disease.
    Shingo T; Date I; Yoshida H; Ohmoto T
    J Neurosci Res; 2002 Sep; 69(6):946-54. PubMed ID: 12205688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurorescue effects of VEGF on a rat model of Parkinson's disease.
    Yasuhara T; Shingo T; Muraoka K; Kameda M; Agari T; Wen Ji Y; Hayase H; Hamada H; Borlongan CV; Date I
    Brain Res; 2005 Aug; 1053(1-2):10-8. PubMed ID: 16045899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Encapsulated dopamine-secreting cells transplanted into the brain: a possible therapy for Parkinson's disease].
    Miyoshi Y; Date I; Ono T; Imaoka T; Asari S; Ohmoto T; Iwata H
    No Shinkei Geka; 1996 Jan; 24(1):35-9. PubMed ID: 8559262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transplantation of a polymer-encapsulated cell line genetically engineered to release NGF.
    Hoffman D; Breakefield XO; Short MP; Aebischer P
    Exp Neurol; 1993 Jul; 122(1):100-6. PubMed ID: 8339781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cografting technique in the treatment of Parkinson's disease].
    Date I; Asari S; Nishimoto A; Felten D
    No Shinkei Geka; 1991 Oct; 19(10):919-24. PubMed ID: 1944775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on immunoisolation cell therapy for CNS diseases.
    Emerich DF; Salzberg HC
    Cell Transplant; 2001; 10(1):3-24. PubMed ID: 11294469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymer-encapsulated PC12 cells promote recovery of motor function in aged rats.
    Emerich DF; McDermott PE; Krueger PM; Frydel B; Sanberg PR; Winn SR
    Exp Neurol; 1993 Jul; 122(1):37-47. PubMed ID: 8339788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Grafting of encapsulated dopamine-secreting cells in Parkinson's disease: long-term primate study.
    Date I; Shingo T; Yoshida H; Fujiwara K; Kobayashi K; Ohmoto T
    Cell Transplant; 2000; 9(5):705-9. PubMed ID: 11144970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenal chromaffin cells transdifferentiate in response to basic fibroblast growth factor and show directed outgrowth to a nerve growth factor source in vivo.
    Chalmers GR; Fisher LJ; Niijima K; Patterson PH; Gage FH
    Exp Neurol; 1995 May; 133(1):32-42. PubMed ID: 7601261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cografts of adrenal medulla and peripheral nerve in a mouse model of Parkinson's disease].
    Date I; Asari S; Nishimoto A; Felten D
    No Shinkei Geka; 1991 Sep; 19(9):811-5. PubMed ID: 1944788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Adrenal medullary graft induces recovery of the host nigrostriatal dopaminergic system in MPTP-induced mouse model of Parkinson's disease].
    Date I; Asari S; Nishimoto A; Felten DL
    No To Shinkei; 1990 Dec; 42(12):1173-8. PubMed ID: 2083133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term survival of encapsulated GDNF secreting cells implanted within the striatum of parkinsonized rats.
    Grandoso L; Ponce S; Manuel I; Arrúe A; Ruiz-Ortega JA; Ulibarri I; Orive G; Hernández RM; Rodríguez A; Rodríguez-Puertas R; Zumárraga M; Linazasoro G; Pedraz JL; Ugedo L
    Int J Pharm; 2007 Oct; 343(1-2):69-78. PubMed ID: 17583454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.